News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Form 4 CHAMPIONS ONCOLOGY, INC. For: Nov 05 Filed by: Breitfeld Philip P.

Form 4 CHAMPIONS ONCOLOGY, INC. For: Nov 05 Filed by: SIDRANSKY DAVID

Form 4 CHAMPIONS ONCOLOGY, INC. For: Nov 05 Filed by: Mendelson Daniel Newman

Form 4 CHAMPIONS ONCOLOGY, INC. For: Nov 05 Filed by: TOBIN SCOTT R

Form 4 CHAMPIONS ONCOLOGY, INC. For: Nov 05 Filed by: ACKERMAN JOEL

Top News Decliners

12/16 Form 8-K CHAMPIONS ONCOLOGY, INC. For: Dec 16 -18.8%

7/15 Champions Oncology Reports Record Quarterly Revenue of $7.7 Million For The Fourth Quarter Ended April 30, 2019 -15.2%

9/16 Q1/2020 7/31/2019 EPS -0.060 ZacksConsensus 0.040 ActVsEst (0.100) - Miss -14.2%

3/17 Champions Oncology Inc (NASDAQ: CSBR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $5.50 price target on the stock. -12.2%

3/10 Form 4 CHAMPIONS ONCOLOGY, INC. For: Mar 06 Filed by: Sonsini Peter W. -7.5%

3/10 Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2020 -6.5%

8/28 Form DEF 14A CHAMPIONS ONCOLOGY, INC. For: Apr 30 -5.1%

11/18 Champions Oncology Inc (NASDAQ: CSBR) is now covered by analysts at Benchmark Co.. They set a "buy" rating on the stock. -5.0%

3/12 Form 4 CHAMPIONS ONCOLOGY, INC. For: Mar 11 Filed by: TABORS R DAVID -3.9%

11/27 Champions Oncology Inc (NASDAQ: CSBR) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $11.00 price target on the stock. -3.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}